Professor Àlex Rovira reviews latest European-North American aligned guidelines on magnetic resonance imaging in multiple sclerosis, which include imaging technology advances and new safety data.
MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
Professor Àlex Rovira serves/ed on scientific advisory boards for Novartis, Sanofi-Genzyme, Synthetic MR, TensorMedical, Roche, Biogen, and OLEA Medical, and has received speaker honoraria from Bayer, Sanofi-Genzyme, Merck-Serono, Teva Pharmaceutical Industries Ltd, Novartis, Roche and Biogen.